De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Lushang Freda PharmaceuticalLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Lushang Freda PharmaceuticalLtd has a total shareholder equity of CN¥4.7B and total debt of CN¥564.8M, which brings its debt-to-equity ratio to 11.9%. Its total assets and total liabilities are CN¥6.3B and CN¥1.6B respectively. Lushang Freda PharmaceuticalLtd's EBIT is CN¥175.5M making its interest coverage ratio -1.7. It has cash and short-term investments of CN¥3.2B.
Belangrijke informatie
11.9%
Verhouding schuld/eigen vermogen
CN¥564.79m
Schuld
| Rente dekkingsratio | -1.7x |
| Contant | CN¥3.24b |
| Aandelen | CN¥4.73b |
| Totaal verplichtingen | CN¥1.61b |
| Totaal activa | CN¥6.35b |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Doing What It Can To Lift Shares
Jun 21
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27Analyse van de financiële positie
Kortlopende schulden: 600223's short term assets (CN¥4.5B) exceed its short term liabilities (CN¥1.5B).
Langlopende schulden: 600223's short term assets (CN¥4.5B) exceed its long term liabilities (CN¥137.3M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 600223 has more cash than its total debt.
Schuld verminderen: 600223's debt to equity ratio has reduced from 398.6% to 11.9% over the past 5 years.
Schuldendekking: 600223's debt is well covered by operating cash flow (65.5%).
Rentedekking: 600223 earns more interest than it pays, so coverage of interest payments is not a concern.